ICCR & MCMA 2027

Welcome

The 21st International Conference on the use of Computers in Radiation therapy (ICCR) will be held in Québec (Québec) Canada from July 4th to 8th 2027.

ICCR is one of the longest-running conferences in radiation therapy. Held only every three years, it attracts medical physicists, clinicians, and academic scientists from across the globe who are using computers to drive advances in radiation therapy. Many important innovations have been unveiled at ICCR and the conference enjoys a very high standing in the international radiation oncology community.

The 4th International Conference on Monte Carlo Techniques for Medical Applications (MCMA) will be held jointly with ICCR.

MCMA focuses on the latest findings in the field of Monte Carlo radiation transport applied to radiotherapy, radiobiology, radiology and nuclear medicine.

We look forward to welcoming you in Québec in July 2027!

ICCR Topics

Core Computational Methods in Radiation Therapy

• Treatment Planning 

• Dose Calculation 

• Dose Delivery

• Monte Carlo Simulations 

• Radiobiology & Computational Modelling 

• Brachytherapy 

• Targeted Radiation Therapy 

• Motion Management 

Medical Imaging & Image Computing

• Image Guidance 

• Image Reconstruction

• Image Registration 

• Image Segmentation 

• Imaging Biomarkers 

Artificial Intelligence & Machine Learning 

• AI & Machine Learning 

• Generative AI 

• Agentic AI & Autonomous Systems 

• Explainable AI (XAI) 

• QA of AI 

• Prediction Models & Decision Support Systems 

• Radiomics & Radiogenomics 

• Big Data Analytics & Federated Learning 

Human-AI Interaction & Clinical Workflow

• Human-AI Interaction 

• Patient-AI Interaction 

• Clinical Workflow Informatics 

• Auto-Scribing & Clinical Documentation AI 

Software, Security & Infrastructure

• Software Interoperability & Open-Source Development 

• Cybersecurity & Disaster Recovery 

• Software Security & Data Protection 

• Digital Twins 

• Ontology & Data Standards

• Digital Infrastructures

• FAIR Data Management and Datasets

Quality & Safety

• Quality Assurance 

Co-Chairs

• Louis Archambault, Université Laval

• Luc Beaulieu,  Université Laval

• Philippe Després,  Université Laval

Local Organizing Committee

• Jean-François Carrier, PhD, Université de Montréal

• Shirin Enger, PhD, McGill University

• John Kildea, PhD, McGill University

• Louis Gagnon, MD, PhD, Université Laval / CERVO

• Mathieu Goulet, PhD, Centre régional intégré de cancérologie (CRIC)

• Éric Poulin, PhD, CHU de Québec - Université Laval

• Alexandra Rink, PhD, University of Toronto, PMH

• Rowan Thomson, PhD, Carleton University

• James Man Git Tsui, MD, PhD, McGill University

• Martin Vallières, PhD, McGill University

International Scientific Committee

• David Sarrut - CNRS, France 

• Simon Rit - CNRS, France

• Cécile Wolfs - MAASTRO, The Netherlands

• Magdalena Bazalova-Carter, University of Victoria, Canada

• Kristy Brock - The University of Texas MD Anderson Cancer Center, USA 

• Irène Buvat - CNRS, France 

• Åsa Carlsson Tedgren - Karolinska Institutet, Sweden 

• Charles-Antoine Collins-Fekete - UC London, UK

• Joe Deasy - Memorial Sloan Kettering Cancer Center, USA 

• George Dedes - Ludwig-Maximilians-Universität München, Germany 

• Issam El Naqa - University of Michigan, USA 

• Claudio Fiorino - San Raffaele Institute, Italy 

• Susanna Guatelli - University of Wollongong, Australia 

• Sarah Gulliford - University College Hospital London, United Kingdom 

• Mathieu Hatt - INSERM LaTIM, France 

• Gerd Heilemann - Medical University of Vienna, Austria 

• David Jaffray - The University of Texas MD Anderson Cancer Center, USA 

• Marc Kessler - University of Michigan, USA 

• Stine Korreman - Danish Center for Particle Therapy, Denmark 

• Guillaume Landry - LMU Klinikum, Germany 

• Tony Lomax - Paul Scherrer Institute, Switzerland 

• Jamie McClelland - University College London, United Kingdom 

• Todd McNutt - Johns Hopkins University, USA 

• Sandra Meyers, UC San Diego, USA

• Arman Rahmin - University of British Columbia, Canada

• Teo Stanescu - Princess Margaret Hospital, Toronto, Canada

• Nick Reynaert - Institut Jules Bordet, Belgium 

• Charlotte Robert - INSERM Institut Gustave Roussy, France 

• Jan Seuntjens - Princess Margaret Hospital and University of Toronto 

• Gregory Sharp - Massachusetts General Hospital, USA 

• Jan-Jakob Sonke - University of Amsterdam, The Netherlands 

• Marcel van Herk - University of Manchester, United Kingdom 

• Dirk Verellen - Antwerp University, Belgium 

• Frank Verhaegen - MAASTRO, The Netherlands 

• Dimitris Visvikis - INSERM LaTIM, France